Sort
15,842 grants matching “pancreatic cancer”
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
$300,000Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R41 · FY2016 · CA
Oral formulation for novel inhibitor of Ras driven cancers
$300,000Joshua Canzoneri · Adt Pharmaceuticals, Llc · R43 · FY2017 · CA
A Novel Vaccine Strategy to Target Breast Cancer Enabled by Proprietary Mutant Bacteriophage Qbeta-Tumor Antigen Conjugates
$300,000Herbert Wanjala Kavunja · Iaso Therapeutics, Inc. · R43 · FY2020 · CA
Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer
$300,000Valerie Humblet · Collagen Medical, Llc · R44 · FY2015 · CA
Testing of novel anti-cancer compounds Curaxins against pancreatic cancer
$300,000Katerina Gurova · Buffalo Biolabs, Llc · R41 · FY2012 · CA
Developing a plectin-1 targeted imaging agent for the detection of pancreatic can
$299,999Greg Brian Fralish · Iti Health, Inc. · R43 · FY2011 · CA
Novel Single Chain Antibodies against MIF for Prostate Cancer Therapy
$299,999Norman Zhennan Lai · Ibex Biosciences, Llc · R43 · FY2017 · CA
Development of GPER agonists as Cancer Therapeutics
$299,998Todd W Ridky · Linnaeus Therapeutics, Llc · R41 · FY2018 · CA
Combinatorial Brain Cancer Therapy through Irreversible Electroporation and Carbon Nanotubes
$299,998Rafael V Davalos · Virginia Polytechnic Institute And State University · · FY2009 · ENG
Immuno-Oncology for Pancreatic Cancer: A Combination Clinical Trial with Chemotherapy and Radiation
$299,985Estuardo Aguilar-Cordova · Advantagene, Inc · R44 · FY2016 · CA
Development of a vault nanovaccine for pancreatic cancer immunotherapy
$299,979Gayle Boxx · Aukera, Inc. · R43 · FY2019 · CA
Novel targeted therapy for pancreatic cancer
$299,979Victoria L Herrera · Abtelum Biomedical, Inc. · R43 · FY2018 · CA
EAGER: New Biophotonics and Computational Molecular Dynamics for Understanding Epigenetic Regulation of Gene Transcription
$299,958Vadim Backman · Northwestern University · · FY2012 · ENG
Maximizing the safety profile of a novel cancer therapeutic via the de-immunization of an engineered mammalian asparaginase
$299,939Amanda M Schalk · Enzyme By Design, Inc. · R43 · FY2019 · CA
EAGER: Biophotonic Detection of Field Carcinogenesis of Pancreatic Cancer
$299,932Lifang Hou · Northwestern University At Chicago · · FY2013 · ENG
Origins and functions of pancreatic cancer-associated fibroblasts
$299,922Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Unique Anti-microbial Rinse to Reduce Oral Inflammation
$299,915Charles J Gauntt · Biomedical Development Corporation · R44 · FY2012 · HL
Topic 371 - Phase I SBIR Contract - Valudation and Optimization of RP-185 as Adjuvant to Exploit the Immune Response Generated by Radiation
$299,847George Martin · Riptide Bioscience, Inc. · N01 · FY2018 · CA
Alcohol Consumption & Mortality in the US 1950-2000
$299,838William C Kerr · Public Health Institute · R01 · FY2008 · AA
Immunoactivating Peptide AXT201 in Combination with Anti-PD-1 Antibody for Triple-Negative Breast Cancer
$299,815Niranjan B Pandey · Asclepix Therapeutics, Inc. · R43 · FY2019 · CA
Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial
$299,805William Andrew Daunch · Focal Medical, Inc. · R44 · FY2017 · CA
Topic 394 - A versatile radiation-triggered phosphor platform for localized anti-cancer therapy
$299,799Rao Papineni · Pact And Health, Llc · N43 · FY2019 · CA
Mechanistic Studies on New Platinum Clinical Agents
$299,758Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2010 · CA
Multimodality Molecular Nanoimaging of Cancer
$299,756Sanjiv S Gambhir · Stanford University · U54 · FY2019 · CA
Project 2: Targeting Immune Vulnerabilities in Lung Cancer
$299,724John V. Heymach · Ut Southwestern Medical Center · P50 · FY2021 · CA